West Pharmaceutical Services (WST) : Azimuth Capital Management reduced its stake in West Pharmaceutical Services by 0.68% during the most recent quarter end. The investment management company now holds a total of 143,955 shares of West Pharmaceutical Services which is valued at $11,660,355 after selling 985 shares in West Pharmaceutical Services , the firm said in a disclosure report filed with the SEC on Aug 11, 2016.West Pharmaceutical Services makes up approximately 1.01% of Azimuth Capital Management’s portfolio.
Other Hedge Funds, Including , Eam Investors added WST to its portfolio by purchasing 34,249 company shares during the most recent quarter which is valued at $2,799,171. West Pharmaceutical Services makes up approx 0.39% of Eam Investors’s portfolio.Cable Hill Partners boosted its stake in WST in the latest quarter, The investment management firm added 14 additional shares and now holds a total of 260 shares of West Pharmaceutical Services which is valued at $21,250. West Pharmaceutical Services makes up approx 0.01% of Cable Hill Partners’s portfolio.Rs Investment Management Co reduced its stake in WST by selling 333,431 shares or 21.02% in the most recent quarter. The Hedge Fund company now holds 1,253,102 shares of WST which is valued at $98,280,790. West Pharmaceutical Services makes up approx 0.96% of Rs Investment Management Co’s portfolio.New York State Teachers Retirement System boosted its stake in WST in the latest quarter, The investment management firm added 600 additional shares and now holds a total of 131,270 shares of West Pharmaceutical Services which is valued at $10,241,685. West Pharmaceutical Services makes up approx 0.03% of New York State Teachers Retirement System’s portfolio.
West Pharmaceutical Services closed down -0.22 points or -0.27% at $81.34 with 1,68,366 shares getting traded on Tuesday. Post opening the session at $82.1, the shares hit an intraday low of $81.34 and an intraday high of $82.28 and the price fluctuated in this range throughout the day.Shares ended Tuesday session in Red.
On the company’s financial health, West Pharmaceutical Services reported $0.60 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Jul 28, 2016. Analyst had a consensus of $0.56. The company had revenue of $388.00 million for the quarter, compared to analysts expectations of $384.58 million. The company’s revenue was up 7.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.47 EPS.
West Pharmaceutical Services Inc. is a manufacturer of components and systems for the packaging and delivery of injectable drugs as well as delivery system components for the pharmaceutical healthcare and consumer products industries. The Company’s products include stoppers and seals for vials prefillable syringe components and systems components for intravenous and blood collection systems safety and administration systems advanced injection systems and contract design and manufacturing services. The Company’s customers include producers of pharmaceuticals biologics medical devices and personal care products. The Company’s reportable segments include Pharmaceutical Packaging Systems segment (Packaging Systems) and the Pharmaceutical Delivery Systems segment (Delivery Systems).